![Quiver Logo](/static/img/logo-icon.png)
![CLNNW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/clnnw.png)
Clene Inc. Warrant
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CLNNW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CLNNW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CLNNW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CLNNW
Recent picks made for CLNNW stock on CNBC
ETFs with the largest estimated holdings in CLNNW
Flights by private jets registered to CLNNW
![Quiver Logo](/static/img/logo-icon.png)